These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14501013)

  • 1. Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening.
    Chang L; Bakhos L; Wang Z; Venton DL; Klein WL
    J Mol Neurosci; 2003; 20(3):305-13. PubMed ID: 14501013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
    Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
    Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Per-6-substituted beta-cyclodextrin libraries inhibit formation of beta-amyloid-peptide (A beta)-derived, soluble oligomers.
    Yu J; Bakhos L; Chang L; Holterman MJ; Klein WL; Venton DL
    J Mol Neurosci; 2002; 19(1-2):51-5. PubMed ID: 12212793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies that target pathological assemblies of Abeta.
    Lambert MP; Velasco PT; Chang L; Viola KL; Fernandez S; Lacor PN; Khuon D; Gong Y; Bigio EH; Shaw P; De Felice FG; Krafft GA; Klein WL
    J Neurochem; 2007 Jan; 100(1):23-35. PubMed ID: 17116235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss.
    Gong Y; Chang L; Viola KL; Lacor PN; Lambert MP; Finch CE; Krafft GA; Klein WL
    Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10417-22. PubMed ID: 12925731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
    Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C
    J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid β-Derived Diffusible Ligands (ADDLs) Induce Abnormal Autophagy Associated with Aβ Aggregation Degree.
    Wen J; Fang F; Guo SH; Zhang Y; Peng XL; Sun WM; Wei XR; He JS; Hung T
    J Mol Neurosci; 2018 Feb; 64(2):162-174. PubMed ID: 29260451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Prion Peptide 107-120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer's Disease.
    Rezvani Boroujeni E; Hosseini SM; Fani G; Cecchi C; Chiti F
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo.
    Hong HS; Rana S; Barrigan L; Shi A; Zhang Y; Zhou F; Jin LW; Hua DH
    J Neurochem; 2009 Feb; 108(4):1097-1108. PubMed ID: 19141069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of ADDL--targeting small molecule drugs for Alzheimer's disease.
    Look GC; Jerecic J; Cherbavaz DB; Pray TR; Breach JC; Crosier WJ; Igoudin L; Hironaka CM; Lowe RM; McEntee M; Ruslim-Litrus L; Wu HM; Zhang S; Catalano SM; Goure WF; Summa D; Krafft GA
    Curr Alzheimer Res; 2007 Dec; 4(5):562-7. PubMed ID: 18220523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets.
    Klein WL
    Neurochem Int; 2002 Nov; 41(5):345-52. PubMed ID: 12176077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
    Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
    Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
    Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
    CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.
    Balducci C; Mancini S; Minniti S; La Vitola P; Zotti M; Sancini G; Mauri M; Cagnotto A; Colombo L; Fiordaliso F; Grigoli E; Salmona M; Snellman A; Haaparanta-Solin M; Forloni G; Masserini M; Re F
    J Neurosci; 2014 Oct; 34(42):14022-31. PubMed ID: 25319699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.
    Meilandt WJ; Cisse M; Ho K; Wu T; Esposito LA; Scearce-Levie K; Cheng IH; Yu GQ; Mucke L
    J Neurosci; 2009 Feb; 29(7):1977-86. PubMed ID: 19228952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
    Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
    Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease.
    Catalano SM; Dodson EC; Henze DA; Joyce JG; Krafft GA; Kinney GG
    Curr Top Med Chem; 2006; 6(6):597-608. PubMed ID: 16712494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis.
    Xue D; Zhao M; Wang YJ; Wang L; Yang Y; Wang SW; Zhang R; Zhao Y; Liu RT
    Neurobiol Dis; 2012 Jun; 46(3):701-9. PubMed ID: 22426388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
    Fang XT; Hultqvist G; Meier SR; Antoni G; Sehlin D; Syvänen S
    Neuroimage; 2019 Jan; 184():881-888. PubMed ID: 30300753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.